BERKELEY, Calif.--(BUSINESS WIRE)--Valor Compounding Pharmacy offers low-dose naltrexone, ketamine, and other alternative treatment options for the growing mental health crisis in the United States.

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...

BERKELEY, Calif.--(BUSINESS WIRE)--CIO Bulletin, an interactive leadership platform, has named Valor Compounding Pharmacy one of the 50 Best Companies to Watch. The distinction comes hand in hand with ...

Compounded NAD+ Telehealth Access, FDA Classification, Pharmacy Sourcing Standards, Prescription Requirements, and Consumer ...

The FDA’s approval of the drug Aduhelm as a treatment for Alzheimer’s disease — despite the recommendation of its own advisory committee against approval — came as a surprise to many. But to me, that ...

If you’ve received medication through popular telemedicine companies like Hims & Hers Health, you’re probably familiar with drug compounding. That’s the process of creating customized medicine for a ...

Sterile compounding has long been recognized as a high-risk area of health system pharmacy. Traditional manual IV compounding techniques can be prone to human error, leading to incorrect ingredients ...

AUSTIN, Texas — “The reason I contacted you is that I wanted you to know that compounding pharmacy, good community compounding pharmacy still exists,” said Daniel Dougharty, business developer for ...

Compounding pharmacies can offer a life-saving medicine to patients who may not be able to take standard medication, but the industry is in the midst of challenges because of rules and regulations ...

By Mariam Sunny March 3 (Reuters) - Strive Pharmacy said on Tuesday it has no plans to resume sales of a compounded version of Novo Nordisk's oral semaglutide, pushing back on an earlier media report ...

The MarketWatch News Department was not involved in the creation of this content. Lawsuit alleges anti-competitive conduct designed to suppress lawful compounding pharmaceuticals and limit patient ...